Clinical periodontal and microbiologic parameters in patients with crohn's disease with consideration of the CARD15 genotype

Journal of Periodontology

Volumn 81, Issue 4, 2010, Pages 535-545

  Stein, Jamal M ^a   Lammert, Frank ^a,b   Zimmer, Vincent ^b   Granzow, Marie ^a   Reichert, Stefan ^c   Schulz, Susanne ^c   Ocklenburg, Christina ^a   Conrads, Georg ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Bacteria; Campylobacter rectus; CARD15 protein; Crohn's disease; Inflammatory bowel diseases; Periodontitis

Indexed keywords

BACTERIAL DNA; CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLELE; ANAEROBIC BACTERIUM; ARTICLE; CHI SQUARE DISTRIBUTION; CROHN DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIODONTAL POCKET; PERIODONTICS; PERIODONTITIS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADOLESCENT; ADULT; ALLELES; BACTERIA, ANAEROBIC; CHI-SQUARE DISTRIBUTION; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOD2 SIGNALING ADAPTOR PROTEIN; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77950667671     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090563     Document Type: Article

References (56)

1. Probert CS, Jayanthi V, Hughes AO, Thompson JR, Wicks AC, Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn's disease: An epidemio-logical study among Europeans and south Asians in Leicestershire. Gut 1993;34:1547-1551.
2. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-1429.
3. Brandtzaeg P. Inflammatory bowel disease: Clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol Scand 2001;59:235-243.
4. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928-937.
5. Dudeney TP. Crohn's disease of the mouth. Proc R Soc Med 1969;62:1237.
6. Carr D. Granulomatous cheilitis in Crohn's disease. Br Med J (Clin Res Ed) 1974;4:636.
7. Snyder MB, Cawson RA. Oral changes in Crohn's disease. J Oral Surg 1976;34:594-599.
8. Beitman RG, Frost SS, Roth JL. Oral manifestations of gastrointestinal disease. Dig Dis Sci 1981;26:741-747.
9. Engel LD, Pasquinelli KL, Leone SA, Moncla BJ, Nielson KD, Rabinovitch PS. Abnormal lymphocyte profiles and leukotriene B4 status in a patient with Crohn's disease and severe periodontitis. J Periodontol 1988;59:841-847.
10. Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol 1991;13:29-37.
11. Scheper HJ, Brand HS. Oral aspects of Crohn's disease. Int Dent J 2002;52:163-172.
12. Ruiz-Roca JA, Berini-Aytés L, Gay-Escoda C. Pyosto-matitis vegetans. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:447-454.
13. Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol 2005;3:886-891.
14. Williams AJ, Wray D, Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med 1991;79:451-458.
15. Flemmig TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. J Clin Periodontol 1991; 18:690-697.
16. Grössner-Schreiber B, Fetter T, Hedderich J, Kocher T, Schreiber S, Jepsen S. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: A case-control study. J Clin Periodontol 2006;33:478-484.
17. Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol 2008; 35:555-560.
18. Van Dyke TE, Dowell VR Jr., Offenbacher S, Snyder W, Hersh T. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 1986;53: 671-677.
19. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357:1925-1928
20. (erratum 2002;360:806).
21. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: A cohort study. Lancet 2002;359: 1661-1665.
22. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411: 599-603.
23. Lesage S, Zouali H, Cézard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-857.
24. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606.
25. Tukel T, Shalata A, Present D, et al. Crohn disease: Frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet 2004;74:623-636.
26. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-4818.
27. Kalmar JR. Crohn's disease: Orofacial considerations and disease pathogenesis. Periodontol 2000 1994; 6:101-115.
28. MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000;51:2-9.
29. Kinane DF, Mark Bartold P. Clinical relevance of the host responses of periodontitis. Periodontol 2000 2007;43:278-293.
30. Stoll M, Corneliussen B, Costello CM, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004;36:476-480.
31. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;170 (Suppl.):2-6; discussion 16-19.
32. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610-616.
33. Holborow DW. The Community Periodontal Index of Treatment Needs - Uses and abuses? N Z Dent J 1998;94:120-121.
34. Conrads G, Mutters E, Fischer J, Brauner A, Lütticken R, Lampert F. PCR reaction and dot-blot hybridization to monitor the distribution of oral pathogens within plaque samples of periodontally healthy individuals. J Periodontol 1996;67:994-1003.
35. Talbot T, Jewell L, Schloss E, Yakimets W, Thomson AB. Cheilitis antedating Crohn's disease: Case report and literature update of oral lesions. J Clin Gastroenterol 1984;6:349-354.
36. Field EA, Tyldesley WR. Oral Crohn's disease revisited - A 10-year-review. Br J Oral Maxillofac Surg 1989;27: 114-123.
37. Ficarra G, Cicchi P, Amorosi A, Piluso S. Oral Crohn's disease and pyostomatitis vegetans. An unusual association. Oral Surg Oral Med Oral Pathol 1993;75: 220-224.
38. Lamster IB, Rodrick ML, Sonis ST, Falchuk ZM. An analysis of peripheral blood and salivary polymor-phonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease. J Periodontol 1982;53: 231-238.
39. Halme L, Meurman JH, Laine P, et al. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol 1993;76:175-181.
40. Coenen C, Börsch G, Müller KM, Fabry H. Oral inflammatory changes as an initial manifestation of Crohn's disease antedating abdominal diagnosis. Report of a case. Dis Colon Rectum 1988;31:548-552.
41. Thomson WM, Williams SM. Partial- or full-mouth approaches to assessing the prevalence of and risk factors for periodontal disease in young adults. J Periodontol 2002;73:1010-1014.
42. Micheelis W, Schiffner U. Fourth German Oral Health Survey (DMS IV) (in German). Köln, Germany: Deutscher Zahnärzte Verlag; 2006:275.
43. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-8872.
44. Folwaczny M, Glas J, Török HP, Mauermann D, Folwaczny C. The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease. Eur J Oral Sci 2004;112:316-319.
45. Noack B, Görgens H, Hoffmann T, Schackert HK. CARD15 gene variants in aggressive periodontitis. J Clin Periodontol 2006;33:779-783.
46. Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: The "red complex," a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005; 38:72-122.
47. Haffajee AD, Cugini MA, Tanner A, et al. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol 1998;25:346-353.
48. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
49. Kamma JJ, Nakou M, Manti FA. Predominant micro-flora of severe, moderate and minimal periodontal lesions in young adults with rapidly progressive periodontitis. J Periodontal Res 1995;30:66-72.
50. Laine ML, Murillo LS, Morré SA, Winkel EG, Peña AS, van Winkelhoff AJ. CARD15 gene mutations in periodontitis. J Clin Periodontol 2004;31:890-893.
51. Schmaldienst S, Horl WH. Bacterial infections during immunosuppression - Immunosuppressive agents interfere not only with immune response, but also with polymorphonuclear cell function. Nephrol Dial Transplant 1996;11:1243-1245.
52. Thompson SA. Campylobacter surface-layers (S-layers) and immune evasion. Ann Periodontol 2002;7:43-53.
53. Hinode D, Yokoyama M, Tanabe S, Yoshioka M, Nakamura R. Antigenic properties of the GroEL-like protein of Campylobacter rectus. Oral Microbiol Immunol 2002;17:16-21.
54. Tanabe S, Hinode D, Yokoyama M, et al. Helicobacter pylori and Campylobacter rectus share a common antigen. Oral Microbiol Immunol 2003;18:79-87.
55. Schulte CM, Dignass AU, Goebell H, Röher HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000;119:909-920.
56. Bene L, Füst G, Huszti Z, et al. Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease. Dig Dis Sci 2002;47:1432-1437.